Alkermes ALKS
NASDAQ ALKS
$40.58 +0.06 (+0.16%)
As of: Oct 1, 2026 · 2:56 PM EDT

Alkermes (ALKS) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Alkermes' Net Equity Issued and Repurchased came in at $26.29 million for Q2 2026, compared with $2.08 million a year earlier and up 67.3% from the prior quarter.

Analysis

Alkermes (ALKS) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alkermes reported Net Equity Issued and Repurchased of $53.81 million, up 18.6% year-over-year; for FY2025, it came in at $43.41 million, up 57.4% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 39.0% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $27.57 million in FY2024 (+64.5%), $16.76 million in FY2023 (-14.6%), $19.63 million in FY2022 (-22.5%) and $25.32 million in FY2021 (+202.4%).
  • The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
  • Year-over-year, Net Equity Issued and Repurchased increased in four of the last seven quarters, with growth averaging 74.3%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q3 2021 (growth of 439.0%), and the weakest in Q3 2025 (a decline of 88.7%).
  • Business Quant data shows ALKS's Net Equity Issued and Repurchased at $15.71 million (Q1 2026), $11.18 million (Q4 2025) and $622,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Alkermes 6.79 Bn 3.92 Bn 397.90 Mn 26.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.29 Mn
Mar 31, 2026 15.71 Mn
Dec 31, 2025 11.18 Mn
Sep 30, 2025 622,000.00
Jun 30, 2025 2.08 Mn
Mar 31, 2025 29.53 Mn
Dec 31, 2024 8.22 Mn
Sep 30, 2024 5.52 Mn
Jun 30, 2024 2.61 Mn
Mar 31, 2024 11.23 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 3.11 Mn
Jun 30, 2023 9.13 Mn
Mar 31, 2023 2.87 Mn
Dec 31, 2022 780,000.00
Sep 30, 2022 858,000.00
Jun 30, 2022 16.20 Mn
Mar 31, 2022 1.80 Mn
Dec 31, 2021 509,000.00
Sep 30, 2021 4.31 Mn
API Access

Alkermes Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALKS&period=max&api_key=YOUR_API_KEY